GenFleet Therapeutics competitorsClear all

GenFleet Therapeutics's top competitors include Amoy Diagnostics, Kahr medical, ChemoCentryx and Priothera.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
GenFleet Therapeutics
GenFleet Therapeutics
GenFleet Therapeutics is a company that develops and researches molecular pharmaceuticals targeting cancer treatments.
Amoy Diagnostics
Amoy Diagnostics
Amoy Diagnostics (AmoyDx, 艾德生物) is a company that provides molecular diagnostic products and services for oncology precision medicine.
Kahr medical
Kahr medical
Kahr medical is a company that develops a novel drug platform designed to offer immuno-oncology therapies.
ChemoCentryx
ChemoCentryx
ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer.
Priothera
Priothera
Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.
Founding Date
Founding Date
2017
Founding Date
2008
Founding Date
2005
Founding Date
1997
Founding Date
2020
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
CN HQ
Shaoxing Shi, CN
Shaoxing Shi, CN
Locations
Xiamen, CN HQ
Locations
Jerusalem, IL HQ
Locations
San Carlos, US HQ
Locations
Dublin, IE HQ
Employees
Employees
N/A
Employees
65421% increase
Employees
26
Employees
13362% increase
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.6 b
Valuation ($)
N/A
Valuation ($)
2.3 b
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
326
Twitter followers
11
Twitter followers
623
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
233230
Alexa Website Rank
295032
Alexa Website Rank
522105
Alexa Website Rank
146268
Alexa Website Rank
183065

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥578.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$64.9m (FY, 2020)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
¥135.5m (FY, 2019)
Net income
N/A
Net income
($55.4m) (FY, 2020)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 58m (almost 2 years ago)
Latest funding round
N/A
Latest funding round
$ 18m (almost 2 years ago)
Latest funding round
N/A
Latest funding round
$ 35.5m (over 1 year ago)
Total funding raised
Total funding raised
$ 89m
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 149.5m
Total funding raised
$ 35.5m
For sources of this data, please see the company profile

View company profiles

Amoy Diagnostics
HQ
Xiamen, CN
Employees
654↑ 21% increase

Amoy Diagnostics (AmoyDx, 艾德生物) is a company that provides molecular diagnostic products and services for oncology precision medicine.

View company
Kahr medical
HQ
Jerusalem, IL
Employees
26

Kahr medical is a company that develops a novel drug platform designed to offer immuno-oncology therapies.

View company
ChemoCentryx
HQ
San Carlos, US
Employees
133

ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of medications targeting inflammatory disorders, autoimmune diseases, and cancer.

View company
Priothera
HQ
Dublin, IE

Priothera is a company that develops receptor modulators intended to improve the lives of patients suffering from hematological malignancies.

View company